Multiple sclerosis - emerging concepts of disease pathogenesis

被引:23
作者
Antel, J [1 ]
机构
[1] Montreal Neurol Hosp & Inst, Montreal, PQ H3A 2B4, Canada
关键词
multiple sclerosis; pathogenesis; etiology;
D O I
10.1016/S0165-5728(99)00080-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis has been recognized as a clinical pathologic entity for more than a century. The pioneering microscopic anatomic studies of Charcot illustrate the power of careful observations taking maximal advantage of available technology. Using carmine as 'a precious agent' to stain spinal cord hardened with dilute chromic acid, he described the characteristic myelin loss with relative but not absolute axonal preservation. This presentation summarizes how following the principle of careful application of emerging technologies to MS patients and their tissues, as described in this symposium, as the foundation for our continuing advances regarding the etiology and pathogenesis of MS. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 24 条
[1]   Magnetic resonance spectroscopy: imaging axonal damage in MS [J].
Arnold, DL .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 98 (01) :2-6
[2]   CD95-CD95L: can the brain learn from the immune system? [J].
Becher, B ;
Barker, PA ;
Owens, T ;
Antel, JP .
TRENDS IN NEUROSCIENCES, 1998, 21 (03) :114-117
[3]   The origin of remyelinating cells in the central nervous system [J].
Blakemore, WF ;
Keirstead, HS .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 98 (01) :69-76
[4]   Monitoring relapsing remitting MS patients [J].
Bourdette, D ;
Antel, J ;
McFarland, H ;
Montgomery, E .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 98 (01) :16-21
[5]  
CHARCOT JM, 1876, LECT DIS NERVOUS SYT, V1, P157
[6]   Chemical pathology of acute demyelinating lesions and its correlation with disability [J].
DeStefano, N ;
Matthews, PM ;
Antel, JP ;
Preul, M ;
Francis, G ;
Arnold, DL .
ANNALS OF NEUROLOGY, 1995, 38 (06) :901-909
[7]   Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis [J].
Frei, K ;
Eugster, HP ;
Bopst, M ;
Constantinescu, CS ;
Lavi, E ;
Fontana, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (12) :2177-2182
[8]   Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: Enhancement by monoclonal antibodies against interferon-gamma [J].
Heremans, H ;
Dillen, C ;
Groenen, M ;
Martens, E ;
Billiau, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) :2393-2398
[9]   TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: An overview [J].
Klinkert, WEF ;
Kojima, K ;
Lesslauer, W ;
Rinner, W ;
Lassmann, H ;
Wekerle, H .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 72 (02) :163-168
[10]   Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system [J].
Korner, H ;
Lemckert, FA ;
Chaudhri, G ;
Etteldorf, S ;
Sedgwick, JD .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) :1973-1981